Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Linear Ablation Added to Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Pulsed Field Ablation for Persistent Atrial Fibrillation: a Multi-center Randomized Controlled Trial

NCT07106970 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT07106970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07106970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Linear Ablation Added to Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Pulsed Field Ablation for Persistent Atrial Fibrillation: a Multi-center Randomized Controlled Trial
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
August 28, 2025
Completion date
August 30, 2028
Enrollment
640 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation